Latin America Ophthalmic Drugs Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	114 Pages	Triton Market Research	April, 2024	TRTN18748647

Best Price Guarantee
Price	from $1,500
Length	114 Pages
Publisher	Triton Market Research
Published Date	April, 2024
SKU	TRTN18748647

Latin America Ophthalmic Drugs Market 2023-2030

Market Outlook

Triton’s research report infers that the Latin American ophthalmic drugs market is expected to reach a CAGR of 7.41% in the 2023-2030 forecast period. Brazil, Mexico and the Rest of Latin America are examined in this report.

The ophthalmic drugs market in Latin America is witnessing robust growth as the demand for ophthalmic medications is rising. Additionally, the collaborations between healthcare providers and pharmaceutical companies to deliver efficient drug delivery and treatment access improve the ophthalmic drugs market. The rising population of middle-class and elderly is also creating a need to expand the healthcare systems and streamline eye care services.

In order to enhance the accessibility of eye care solutions to Mexican people, the ophthalmic drugs market emerges as a collaboration and innovation hub. The Federal Commission for Protection against Sanitary Risk (COFEPRIS) timely ensures that drug manufacturing companies meet the required standards of safety and efficacy. An increase in healthcare expenditure fosters a culture of innovation and advancements to produce patient-friendly ophthalmic drugs, which leads to the growth of the studied market.

Competitive Outlook

The major companies listed in the ophthalmic drugs market are Johnson & Johnson, Accutome Inc, Regeneron Pharmaceuticals Inc, Novartis AG, Thea Pharma Inc, and Pfizer Inc.

1. Latin America Ophthalmic Drugs Market - Summary
2. Industry Outlook: 2.1. Technology Snapshot; 2.2. Impact Analysis On The Ophthalmic Drugs Market; 2.2.1. Covid-19 Impact On The Ophthalmic Drugs Market; 2.3. Porters Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Market Maturity Analysis; 2.5. Regulatory Framework; 2.6. Key Buying Impact Analysis; 2.7. Key Market Strategies; 2.7.1. Collaborations; 2.7.2. Product Launches; 2.7.3. Mergers & Acquisitions; 2.8. Market Drivers; 2.8.1. Aging Population Vulnerable To Eye Disorders; 2.8.2. Progress In Drug Delivery Technologies; 2.8.3. Escalating Incidence Of Ocular Diseases; 2.8.4. Reimbursement Policies By Healthcare Systems; 2.9. Market Challenges; 2.9.1. Challenging Timelines For Product Approval; 2.9.2. Adverse Effects Associated With Ophthalmic Drug Usage; 2.10. Market Opportunities; 2.10.1. Surge In Interest Regarding Topically Administered Ophthalmic Drugs; 2.10.2. Increase In Approvals For Innovative Ophthalmic Therapies; 2.11. Analyst Perspective
3. Latin America Ophthalmic Drugs Market – By Type: 3.1. Prescription Drugs; 3.2. Over-the-counter Drugs
4. Latin America Ophthalmic Drugs Market – By Condition: 4.1. Dry Eye; 4.2. Glaucoma; 4.3. Infection/Inflammation/Allergies; 4.4. Retinal Disorder; 4.4.1. Wet-age Related Macular Degeneration; 4.4.2. Dry-age Related Macular Degeneration; 4.4.3. Diabetic Retinopathy; 4.4.4. Other Retinal Disorders; 4.5. Other Conditions
5. Latin America Ophthalmic Drugs Market – By Therapeutic Type: 5.1. Anti-glaucoma; 5.2. Anti-infection; 5.3. Anti-inflammatory; 5.4. Anti-allergy; 5.5. Other Therapeutic Types
6. Latin America Ophthalmic Drugs Market – By Delivery Method: 6.1. Gels; 6.2. Eye Solutions & Suspensions; 6.3. Capsules & Tablets; 6.4. Eye Drops; 6.5. Ointments
7. Latin America Ophthalmic Drugs Market – By Channel: 7.1. Hospital Pharmacies; 7.2. Drug Stores; 7.3. Online Pharmacies; 7.4. Other Channels
8. Latin America Ophthalmic Drugs Market – Country Outlook: 8.1. Brazil; 8.1.1. Brazil Ophthalmic Drugs Market Forecast & Prospects; 8.2. Mexico; 8.2.1. Mexico Ophthalmic Drugs Market Forecast & Prospects; 8.3. Rest Of Latin America; 8.3.1. Rest Of Latin America Ophthalmic Drugs Market Forecast & Prospects
9. Competitive Landscape: 9.1. Abbvie Inc; 9.1.1. Overview; 9.1.2. Product Portfolio; 9.1.3. Key Strengths; 9.1.4. Key Challenges; 9.2. Bausch Health Companies Inc; 9.2.1. Overview; 9.2.2. Product Portfolio; 9.2.3. Key Strengths; 9.2.4. Key Challenges; 9.3. Johnson & Johnson; 9.3.1. Overview; 9.3.2. Product Portfolio; 9.3.3. Key Strengths; 9.3.4. Key Challenges; 9.4. Novartis Ag; 9.4.1. Overview; 9.4.2. Product Portfolio; 9.4.3. Key Strengths; 9.4.4. Key Challenges; 9.5. Regeneron Pharmaceuticals Inc; 9.5.1. Overview; 9.5.2. Product Portfolio; 9.5.3. Key Strengths; 9.5.4. Key Challenges; 9.6. Sun Pharmaceutical Industries Ltd; 9.6.1. Overview; 9.6.2. Product Portfolio; 9.6.3. Key Strengths; 9.6.4. Key Challenges; 9.7. Accutome Inc; 9.7.1. Overview; 9.7.2. Product Portfolio; 9.7.3. Key Strengths; 9.7.4. Key Challenges; 9.8. Genentech Inc; 9.8.1. Overview; 9.8.2. Product Portfolio; 9.8.3. Key Strengths; 9.8.4. Key Challenges; 9.9. Thea Pharma Inc; 9.9.1. Overview; 9.9.2. Product Portfolio; 9.9.3. Key Strengths; 9.9.4. Key Challenges; 9.10. Pfizer Inc; 9.10.1. Overview; 9.10.2. Product Portfolio; 9.10.3. Key Strengths; 9.10.4. Key Challenges
10. Research Methodology & Scope: 10.1. Research Scope & Deliverables; 10.2. Sources Of Data; 10.3. Research Methodology
Tables List: Table 1: Latin America Ophthalmic Drugs Market, By Country, 2023-2030 (In $ Million); Table 2: Regulatory Framework; Table 3: List Of Collaborations; Table 4: List Of Product Launches; Table 5: List Of Mergers & Acquisitions; Table 6: Latin America Ophthalmic Drugs Market, By Country Outlook, 2023-2030 (In $ Million); Table 7: Latin America Ophthalmic Drugs Market, By Type, 2023-2030 (In $ Million); Table 8: Latin America Ophthalmic Drugs Market, By Condition, 2023-2030 (In $ Million); Table 9: Latin America Ophthalmic Drugs Market, By Retinal Disorder, 2023-2030 (In $ Million); Table 10: Latin America Ophthalmic Drugs Market, By Therapeutic Type, 2023-2030 (In $ Million); Table 11: Latin America Ophthalmic Drugs Market, By Delivery Method, 2023-2030 (In $ Million); Table 12: Latin America Ophthalmic Drugs Market, By Channel, 2023-2030 (In $ Million)
Figures List: Figure 1: Technology Snapshot; Figure 2: Market Maturity Analysis; Figure 3: Latin America Ophthalmic Drugs Market, By Type, 2022 & 2030 (In %); Figure 4: Latin America Ophthalmic Drugs Market, By Prescription Drugs, 2023-2030 (In $ Million); Figure 5: Latin America Ophthalmic Drugs Market, By Over-the-counter Drugs, 2023-2030 (In $ Million); Figure 6: Latin America Ophthalmic Drugs Market, By Condition, 2022 & 2030 (In %); Figure 7: Latin America Ophthalmic Drugs Market, By Dry Eye, 2023-2030 (In $ Million); Figure 8: Latin America Ophthalmic Drugs Market, By Glaucoma, 2023-2030 (In $ Million); Figure 9: Latin America Ophthalmic Drugs Market, By Infection/Inflammation/Allergies, 2023-2030 (In $ Million); Figure 10: Latin America Ophthalmic Drugs Market, By Retinal Disorder, 2023-2030 (In $ Million); Figure 11: Latin America Ophthalmic Drugs Market, By Retinal Disorder, 2022 & 2030 (In %); Figure 12: Latin America Ophthalmic Drugs Market, By Wet Age-related Macular Degeneration, 2023-2030 (In $ Million); Figure 13: Latin America Ophthalmic Drugs Market, By Dry Age-related Macular Degeneration, 2023-2030 (In $ Million); Figure 14: Latin America Ophthalmic Drugs Market, By Diabetic Retinopathy, 2023-2030 (In $ Million); Figure 15: Latin America Ophthalmic Drugs Market, By Other Retinal Disorders, 2023-2030 (In $ Million); Figure 16: Latin America Ophthalmic Drugs Market, By Other Conditions, 2023-2030 (In $ Million); Figure 17: Latin America Ophthalmic Drugs Market, By Therapeutic Type, 2022 & 2030 (In %); Figure 18: Latin America Ophthalmic Drugs Market, By Anti-glaucoma, 2023-2030 (In $ Million); Figure 19: Latin America Ophthalmic Drugs Market, By Anti-infection, 2023-2030 (In $ Million); Figure 20: Latin America Ophthalmic Drugs Market, By Anti-inflammatory, 2023-2030 (In $ Million); Figure 21: Latin America Ophthalmic Drugs Market, By Anti-allergy, 2023-2030 (In $ Million); Figure 22: Latin America Ophthalmic Drugs Market, By Other Therapeutic Types, 2023-2030 (In $ Million); Figure 23: Latin America Ophthalmic Drugs Market, By Delivery Method, 2022 & 2030 (In %); Figure 24: Latin America Ophthalmic Drugs Market, By Gels, 2023-2030 (In $ Million); Figure 25: Latin America Ophthalmic Drugs Market, By Eye Solutions & Suspensions, 2023-2030 (In $ Million); Figure 26: Latin America Ophthalmic Drugs Market, By Capsules & Tablets, 2023-2030 (In $ Million); Figure 27: Latin America Ophthalmic Drugs Market, By Eye Drops, 2023-2030 (In $ Million); Figure 28: Latin America Ophthalmic Drugs Market, By Ointments, 2023-2030 (In $ Million); Figure 29: Latin America Ophthalmic Drugs Market, By Channel, 2022 & 2030 (In %); Figure 30: Latin America Ophthalmic Drugs Market, By Hospital Pharmacies, 2023-2030 (In $ Million); Figure 31: Latin America Ophthalmic Drugs Market, By Drug Stores, 2023-2030 (In $ Million); Figure 32: Latin America Ophthalmic Drugs Market, By Online Pharmacies, 2023-2030 (In $ Million); Figure 33: Latin America Ophthalmic Drugs Market, By Other Channels, 2023-2030 (In $ Million); Figure 34: Latin America Ophthalmic Drugs Market, By Country Outlook, 2022 & 2030 (In %); Figure 35: Brazil Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 36: Mexico Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 37: Rest Of Latin America Ophthalmic Drugs Market, 2023-2030 (In $ Million)